All Stories

  1. COVID-19 in children with underlying chronic respiratory diseases: survey results from 174 centres
  2. Volatile organic compound breath signatures of children with cystic fibrosis by real-time SESI-HRMS
  3. Alternate gas washout indices: Assessment of ventilation inhomogeneity in mild to moderate pediatric cystic fibrosis lung disease
  4. Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del
  5. Elevated lung clearance index in infants with cystic fibrosis shortly after birth
  6. Lower exhaled nitric oxide in infants with Cystic Fibrosis compared to healthy controls
  7. Inhaled dry powder mannitol in children with cystic fibrosis: A randomised efficacy and safety trial
  8. Respiratory muscle training improves respiratory muscle endurance but not exercise tolerance in children with cystic fibrosis
  9. Perspective on cystic fibrosis and physical activity: Is there a difference compared to healthy individuals?
  10. Newborn screening for cystic fibrosis — The parent perspective
  11. WS03.3 A phase II, randomised, double-blind, placebo-controlled, crossover study of dry powder mannitol in children with cystic fibrosis (CF)
  12. Bronchial hyperreactivity in young children is an independent risk factor for later asthma
  13. Differential interferon response of the cystic fibrosis bronchial epithelium to major and minor group rhinovirus infection
  14. Monitoring asthma in childhood: lung function, bronchial responsiveness and inflammation
  15. Monitoring asthma in children
  16. Asthma bronchiale
  17. Exhaled nitric oxide in symptomatic children at preschool age predicts later asthma
  18. Treatment of acute asthma
  19. Leptin levels in exhaled breath condensate from asthmatic children: a pilot study
  20. Faculty of 1000 evaluation for Parent initiated prednisolone for acute asthma in children of school age: randomised controlled crossover trial.
  21. Aerosol delivery of nebulised budesonide in young children with asthma
  22. Faculty of 1000 evaluation for Variations between hospitals in antireflux procedures in children.
  23. Faculty of 1000 evaluation for Exhaled nitric oxide as a marker of asthma control in smoking patients.
  24. Faculty of 1000 evaluation for Interferon-gamma release assays do not identify more children with active tuberculosis than the tuberculin skin test.
  25. Faculty of 1000 evaluation for Overweight and changes in weight status during childhood in relation to asthma symptoms at 8 years of age.
  26. Efficacy of an Isotonic Small Droplet Size Nebulized DSCG on Asthma Control in Children.
  27. Faculty of 1000 evaluation for Association between paracetamol use in infancy and childhood, and risk of asthma, rhinoconjunctivitis, and eczema in children aged 6-7 years: analysis from Phase Three of the ISAAC programme.
  28. Eicosanoids in exhaled breath condensates in the assessment of childhood asthma
  29. Reply
  30. Effects of montelukast on subjective and objective outcome measures in preschool asthmatic children
  31. Free 3-nitrotyrosine in exhaled breath condensates of children fails as a marker for oxidative stress in stable cystic fibrosis and asthma
  32. Inducible NO synthase expression is low in airway epithelium from young children with cystic fibrosis
  33. Exhaled Breath Condensate and Other Markers in Exhaled Air